Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Quick Stats
58.2
AI Score
HOLD0.09
Volume Ratio
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
KRYS Stock Summary
Last updated Jan 27, 2026
KRYS is currently trading at $283.04, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $122.8 to $295.98.
Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 59.585, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.054, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates KRYS at 58.2/100 with a HOLD recommendation.
KRYS (Krystal Biotech, Inc. Common Stock) Indicators
Last updated Jan 27, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 59.585 |
| CMF (20) | -0.054 |
| ROC (10) | 1.922 |
| ADX (14) | 44.087 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 12.066 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -37.014 |
| MFI (14) | 61.668 |
KRYS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
KRYS Price vs Max Options Open Interest
KRYS Max Change In Options Open Interest
KRYS Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KRYS Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KRYS Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KRYS Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Krystal Biotech, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
KRYS Moving Averages Analysis
KRYS (Krystal Biotech, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated
| Days | MA |
|---|
KRYS Fundamental Analysis
| P/E (Forward) | 37.7358 |
| P/E (Trailing) | 41.9429 |
| Market Cap ($) | 8.1 billion |
| Earnings/Share ($) | 6.66 |
| Net Proft Margin (%) | 0.533 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 6.86 |
| EPS Estimate Next Year ($) | 8.396 |
| WallStreet Target Price ($) | 276.6 |
| Most Recent Quarter |